Unknown

Dataset Information

0

Pregnane X-receptor promotes stem cell-mediated colon cancer relapse.


ABSTRACT: Colorectal cancer lethality usually results from post-treatment relapse in the majority of stage II-IV patients, due to the enhanced resistance of Cancer Stem Cells (CSCs). Here, we show that the nuclear receptor Pregnane X Receptor (PXR, NR1I2), behaves as a key driver of CSC-mediated tumor recurrence. First, PXR is specifically expressed in CSCs, where it drives the expression of genes involved in self-renewal and chemoresistance. Clinically, high levels of PXR correlate with poor recurrence-free survival in a cohort of >200 stage II/III colorectal cancer patients treated with chemotherapy, for whom finding biomarkers of treatment outcome is an urgent clinical need. shRNA silencing of PXR increased the chemo-sensitivity of human colon CSCs, reduced their self-renewal and tumor-initiating potential, and drastically delayed tumor recurrence in mice following chemotherapy. This study uncovers PXR as a key factor for CSC self-renewal and chemoresistance and targeting PXR thus represents a promising strategy to minimize colorectal cancer relapse by selectively sensitizing CSCs to chemotherapy.

SUBMITTER: Planque C 

PROVIDER: S-EPMC5302934 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC5592675 | biostudies-literature
| S-EPMC10074045 | biostudies-literature
| S-EPMC6393239 | biostudies-literature
| S-EPMC1576011 | biostudies-other
| S-EPMC4244584 | biostudies-literature
| S-EPMC5766906 | biostudies-other
2016-08-01 | E-MTAB-3471 | biostudies-arrayexpress
| S-EPMC9281127 | biostudies-literature
| S-EPMC3019262 | biostudies-literature
| S-EPMC6730900 | biostudies-other